Holen Sie sich die Stockscreener-App
35.17
5.71%
-2.13
Handel nachbörslich:
35.59
0.42
+1.19%
Schlusskurs vom Vortag:
$37.30
Offen:
$37.41
24-Stunden-Volumen:
655.10K
Relative Volume:
0.56
Marktkapitalisierung:
$277.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-121.02M
KGV:
-3.1234
EPS:
-11.26
Netto-Cashflow:
$-114.09M
1W Leistung:
+3.47%
1M Leistung:
-7.59%
6M Leistung:
+12.01%
1J Leistung:
-52.28%
1-Tages-Spanne:
$35.00
$38.13
1-Wochen-Bereich:
$33.59
$38.13
52-Wochen-Spanne:
$7.31
$130.00
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Firmenname
Tonix Pharmaceuticals Holding Corp
Sektor
Branche
Telefon
212-980-9155
Adresse
26 MAIN STREET, SUITE 101, CHATHAM, NY
Vergleichen Sie TNXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
35.17 | 277.66M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-04-18 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-04-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2017-08-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2016-09-07 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2015-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-12 | Eingeleitet | Oppenheimer | Outperform |
| 2015-02-17 | Bestätigt | ROTH Capital | Buy |
| 2014-09-29 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Tonix Pharmaceuticals Reports Promising Phase 3 Results for Fibromyalgia Treatment at EULAR 2025 - citybuzz -
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL - GuruFocus
Tonix Pharmaceuticals: Big Risk, Bigger RewardInitiating With A Buy (NASDAQ:TNXP) - Seeking Alpha
Tonix Pharma Presents Data at Rheumatology Congress - TipRanks
Tonix Pharmaceuticals (TNXP) Highlights Fibromyalgia Treatment a - GuruFocus
Tonix Pharmaceuticals (TNXP) Highlights Fibromyalgia Treatment at EULAR 2025 | TNXP Stock News - GuruFocus
Tonix Pharmaceuticals Presented Data and Analyses of - GlobeNewswire
First New Fibromyalgia Treatment in 15 Years Shows Breakthrough Results, FDA Decision Approaches - Stock Titan
Tonix Pharmaceuticals (TNXP) Welcomes New Board Member | TNXP St - GuruFocus
Tonix Pharmaceuticals Announces Appointment of Commercial - GlobeNewswire
Tonix Pharmaceuticals Strengthens Board with Appointment of Jim Hunter - citybuzz -
Tonix Pharmaceuticals Announces Appointment of Commercial Indust - GuruFocus
Tonix Pharmaceuticals Appoints James “Jim” Hunter To Board - citybiz
Tonix Pharmaceuticals (TNXP) Welcomes New Board Member | TNXP Stock News - GuruFocus
Tonix Pharma Appoints James Hunter to Board - TipRanks
Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion? (NASDAQ:TNXP) - Seeking Alpha
Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors | TNXP Stock News - GuruFocus
Tonix Strengthens Board with 40-Year Pharma Veteran as FDA Decision on Fibromyalgia Drug Approaches - Stock Titan
Tonix Pharmaceuticals (TNXP) Files for $500M Mixed Securities Sh - GuruFocus
Tonix Pharmaceuticals stock falls after announcing $225 million share offerings By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals stock falls after announcing $225 million share offerings - Investing.com Nigeria
Tonix Pharmaceuticals (TNXP) Drops After $500M Shelf Filing - GuruFocus
Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble - Benzinga
Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic By Stocktwits - Investing.com India
Oxford Industries, GameStop, Boeing And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals (TNXP) Files for $500M Mixed Securities Shelf | TNXP Stock News - GuruFocus
Tonix Pharmaceuticals Plans Potential Share Sale of Up to $150 Million; Stock Falls Premarket - MarketScreener
Tonix Pharma Signs Major Sales Agreements for Funding - TipRanks
Tonix Pharmaceuticals Holding May Sell Up To $150 Million In Common Stock - marketscreener.com
Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO International Convention - citybuzz -
(TNXP) Long Term Investment Analysis - news.stocktradersdaily.com
Tonix Pharmaceuticals Announces Presentation at the 2025 BIO Int - GuruFocus
Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention | TNXP Stock News - GuruFocus
Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention - The Manila Times
Tonix Fibromyalgia Drug Faces Critical FDA Decision: CEO to Present Latest Data at BIO 2025 - Stock Titan
Analysis of Tonix Pharmaceuticals (TNXP) Stock: Performance, News for June 2025 - Investing.com India
Tonix Pharmaceuticals doses first patient in Phase 2 OASIS trial for acute stress reaction - Proactive Investors
Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025 - citybuzz -
Tonix Pharmaceuticals Announces Poster Presentation at the Annua - GuruFocus
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 | TNXP Stock News - GuruFocus
Tonix Pharmaceuticals Announces Poster Presentation at the - GlobeNewswire
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 - The Manila Times
Tonix New Fibromyalgia Drug Shows Dual Sleep and Pain Benefits at EULAR 2025 | TNXP Stock News - Stock Titan
Northern Trust Corp Acquires New Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Defense World
Tonix Pharmaceuticals (TNXP) Price Target Raised to $65 by Alliance Global Partners | TNXP Stock News - GuruFocus
Wall Street Zen Downgrades Tonix Pharmaceuticals (NASDAQ:TNXP) to Sell - Defense World
Tonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky Bet (NASDAQ:TNXP) - Seeking Alpha
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights - Revista ADVFN
How the (TNXP) price action is used to our Advantage - news.stocktradersdaily.com
Tonix Pharmaceuticals (TNXP) Stock Surges Over 10%: What's Fueling the Rally and What's Next? - Daily Chhattisgarh News
Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):